Exhibit 107

Calculation of Filing Fee Tables

Form S-4

(Form Type)

GRAPHITE BIO, INC.

(Exact Name of Registrant as Specified in its Charter)

Table 1 - Newly Registered and Carry Forward Securities

	Security Type	Security Class Title	Fee  Calculation  or Carry Forward Rule	Amount Registered	Proposed  Maximum  Offering Price Per Unit	Maximum Aggregate Offering Price	Fee Rate	Amount of  Registration  Fee	Carry  Forward  Form Type	Carry  Forward  File Number	Carry  Forward  Initial effective date	Filing Fee Previously Paid In  Connection  with Unsold Securities to be Carried Forward
Newly Registered Securities
Fees to Be  Paid	Equity	Common Stock, $0.00001 par value  per share	Other	94,549,950 (1)	(2)	$31,516.65 (2)	$0.00014760	$4.66
Fees  Previously  Paid	—	—	—	—	—	—		—
Carry Forward Securities
Carry  Forward  Securities	—	—	—	—		—			—	—	—	—
	Total Offering Amounts					$31,516.65 (2)	—	$4.66
	Total Fees Previously Paid							—
	Total Fee Offsets							—
	Net Fee Due							$4.66

(1) Relates to common stock, $0.00001 par value per share, of Graphite Bio, Inc., a Delaware corporation (“Graphite”), issuable to holders of common stock, $0.001 par value per share and warrants of Lenz Therapeutics, Inc., a Delaware corporation (“Lenz”), in the proposed merger of Generate Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Graphite, with and into Lenz, with Lenz surviving as a wholly owned subsidiary of Graphite, and Lenz being the surviving corporation of the merger. The amount of common stock of Graphite to be registered includes the estimated maximum number of shares of common stock of Graphite that are expected to be issued (or become issuable) pursuant to the merger, without taking into account the effect of a reverse stock split of common stock of Graphite, assuming an estimated pre-split exchange ratio (which is subject to adjustment prior to the closing of the merger) of approximately 1.4135 shares of common stock of Graphite for each outstanding share of common stock of Lenz.

(2) Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(f)(2) of the U.S. Securities Act of 1933, as amended. Lenz is a private company, no market exists for its securities, and it has an accumulated capital deficit. Therefore, the proposed maximum aggregate offering price for the shares expected to be issued pursuant to the merger is one-third of the aggregate par value of the Lenz securities expected to be exchanged in the proposed merger.